仟源医药(300254)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300254 仟源医药

已收盘 12-26 15:00:00

{"stockData":{"symbol":"300254","market":"SZ","secType":"STK","nameCN":"仟源医药","latestPrice":10.13,"timestamp":1766732613000,"preClose":10.19,"halted":0,"volume":4376400,"delay":0,"changeRate":-0.0059,"floatShares":224000000,"shares":256000000,"eps":0.0796,"marketStatus":"已收盘","change":-0.06,"latestTime":"12-26 15:00:00","open":10.18,"high":10.34,"low":10.1,"amount":44690400,"amplitude":0.0236,"askPrice":10.14,"askSize":60,"bidPrice":10.13,"bidSize":47,"shortable":0,"etf":0,"ttmEps":0.0796,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":5,"adr":0,"adjPreClose":10.19,"symbolType":"stock","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":11.21,"lowLimit":9.17,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":256108563,"isCdr":false,"pbRate":8.87,"roa":"--","peRate":127.261307,"roe":"8.1%","epsLYR":0.1746,"committee":0.494963,"marketValue":2594000000,"turnoverRate":0.0195,"status":1,"floatMarketCap":2273000000},"requestUrl":"/m/hq/s/300254","defaultTab":"news","newsList":[{"id":"2585184461","title":"11月24日仟源医药发布公告，股东减持119.71万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585184461","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585184461?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:01","pubTimestamp":1763985674,"startTime":"0","endTime":"0","summary":"证券之星消息，11月24日仟源医药发布公告《仟源医药:简式权益变动报告书》，其股东翁占国于2025年11月20日至2025年11月21日间合计减持119.71万股，占公司目前总股本的0.4674%，变动期间该股股价下跌7.7%，截止11月21日收盘报10.07元。股东增减持详情见下表：根据仟源医药2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400030276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0046","BK0077","300254","BK0114","BK0239"],"gpt_icon":0},{"id":"2585118471","title":"11月21日仟源医药现1笔折价15.19%的大宗交易 合计成交825.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118471","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585118471?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:11","pubTimestamp":1763719870,"startTime":"0","endTime":"0","summary":"证券之星消息，11月21日仟源医药发生大宗交易，交易数据如下：大宗交易成交价格8.54元，相对当日收盘价折价15.19%，成交96.71万股，成交金额825.89万元，买方营业部为国泰海通证券股份有限公司大同向阳街证券营业部，卖方营业部为国泰海通证券股份有限公司大同向阳街证券营业部。近三个月该股共发生3笔大宗交易，合计成交2.42万手，折价成交3笔。截至2025年11月21日收盘，仟源医药报收于10.07元，下跌5.62%，换手率5.15%，成交量11.56万手，成交额1.18亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100028319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","BK0042","BK0077","BK0046","300254","BK0028"],"gpt_icon":0},{"id":"2584491450","title":"11月19日仟源医药现1笔折价17.32%的大宗交易 合计成交902万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584491450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584491450?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:26","pubTimestamp":1763544378,"startTime":"0","endTime":"0","summary":"证券之星消息，11月19日仟源医药发生大宗交易，交易数据如下：大宗交易成交价格9.02元，相对当日收盘价折价17.32%，成交100万股，成交金额902万元，买方营业部为国泰海通证券股份有限公司大同向阳街证券营业部，卖方营业部为国泰海通证券股份有限公司大同向阳街证券营业部。近三个月该股共发生2笔大宗交易，合计成交1.45万手，折价成交2笔。截至2025年11月19日收盘，仟源医药报收于10.91元，下跌3.19%，换手率4.81%，成交量10.79万手，成交额1.18亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900027614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0077","300254","BK0114","BK0239","BK0046","BK0028"],"gpt_icon":0},{"id":"2583949302","title":"股市必读：仟源医药（300254）11月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2583949302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583949302?lang=zh_cn&edition=full","pubTime":"2025-11-13 03:36","pubTimestamp":1762976175,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，仟源医药报收于11.09元，上涨1.74%，换手率4.03%，成交量9.04万手，成交额9982.08万元。董秘最新回复投资者： 公司生产那些流感或者感冒药品？公司有治疗呼吸系统药物盐酸氨溴索分散片和复方甘草片，以及家庭药师品牌感冒用药氨咖黄敏胶囊等，感谢您的关注。当日关注点来自交易信息汇总：11月12日主力资金净流入829.81万元，显示主力对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300004595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","BK0042","BK0077","BK0046","BK0028","300254"],"gpt_icon":0},{"id":"2582325731","title":"仟源医药：生产盐酸氨溴索分散片等呼吸系统药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2582325731","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582325731?lang=zh_cn&edition=full","pubTime":"2025-11-12 16:30","pubTimestamp":1762936256,"startTime":"0","endTime":"0","summary":"证券之星消息，仟源医药(300254)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：公司生产那些流感或者感冒药品？仟源医药回复：投资者，您好！公司有治疗呼吸系统药物盐酸氨溴索分散片和复方甘草片，以及家庭药师品牌感冒用药氨咖黄敏胶囊等，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200025693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0042","300254","BK0077","BK0046","BK0239","BK0114"],"gpt_icon":0},{"id":"2579187408","title":"图解仟源医药三季报：第三季度单季净利润同比增长106.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579187408","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579187408?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:04","pubTimestamp":1761764651,"startTime":"0","endTime":"0","summary":"证券之星消息，仟源医药2025年三季报显示，前三季度公司主营收入6.11亿元，同比上升0.44%；归母净利润2232.74万元，同比下降49.43%；扣非净利润1752.7万元，同比下降35.73%；其中2025年第三季度，公司单季度主营收入2.38亿元，同比上升14.82%；单季度归母净利润2194.66万元，同比上升106.06%；单季度扣非净利润2253.87万元，同比上升212.36%；负债率62.76%，投资收益146.94万元，财务费用1752.28万元，毛利率67.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000003039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300254"],"gpt_icon":0},{"id":"2579998909","title":"仟源医药：10月28日高管虞英民减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579998909","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579998909?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:01","pubTimestamp":1761742916,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月29日市场公开信息、上市公司公告及交易所披露数据整理，仟源医药（300254）最新董监高及相关人员股份变动情况：2025年10月28日公司高管虞英民共减持公司股份1.0万股，占公司总股本为0.0039%。变动期间公司股价上涨3.01%，10月28日当日收盘报11.28元。仟源医药近半年内的董监高及核心技术人员增减持详情如下：仟源医药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900042613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","BK0114","300254","BK0046","BK0042"],"gpt_icon":0},{"id":"2577936393","title":"仟源医药最新公告：股东翁占国拟减持不超3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2577936393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577936393?lang=zh_cn&edition=full","pubTime":"2025-10-22 18:49","pubTimestamp":1761130184,"startTime":"0","endTime":"0","summary":"仟源医药(300254.SZ)公告称，持股5%以上股东翁占国计划自公告披露之日起15个交易日后的3个月内（即2025年11月13日至2026年2月12日），以集中竞价和大宗交易方式减持公司股份不超过768.31万股（占公司总股本比例不超过3%），减持原因为个人资金需求。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200031432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0028","BK0077","300254","BK0114","BK0239"],"gpt_icon":0},{"id":"2577351132","title":"10月22日仟源医药现492.3万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2577351132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577351132?lang=zh_cn&edition=full","pubTime":"2025-10-22 16:55","pubTimestamp":1761123334,"startTime":"0","endTime":"0","summary":"证券之星消息，10月22日仟源医药发生大宗交易，交易数据如下：大宗交易成交价格10.94元，相对当日收盘价折价0.55%，成交45万股，成交金额492.3万元，买方营业部为华宝证券股份有限公司合肥潜山路证券营业部，卖方营业部为方正证券股份有限公司上海杨高南路证券营业部。近三个月该股共发生1笔大宗交易，合计成交4500.0手，折价成交1笔。截至2025年10月22日收盘，仟源医药报收于11.0元，上涨0.27%，换手率3.45%，成交量7.74万手，成交额8533.38万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200025928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","BK0046","BK0077","300254","BK0114","BK0028"],"gpt_icon":0},{"id":"2576305146","title":"仟源医药（300254）披露2024年限制性股票激励计划部分限制性股票回购注销完成公告，10月17日股价下跌1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576305146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576305146?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:53","pubTimestamp":1760712789,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，仟源医药报收于10.77元，较前一交易日下跌1.1%，最新总市值为27.58亿元。公司近日发布公告称，山西仟源医药集团股份有限公司已完成2024年限制性股票激励计划部分限制性股票的回购注销。本次回购注销的限制性股票数量为6.00万股，涉及1名激励对象，占回购前总股本的0.0234%，回购价格为4.73元/股，回购金额合计286,880.20元，资金来源为公司自有资金。本次回购注销完成后，公司总股本由256,168,563股变更为256,108,563股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","BK0042","BK0077","BK0046","300254","BK0028"],"gpt_icon":0},{"id":"2571281893","title":"仟源医药：9月29日高管虞英民减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2571281893","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571281893?lang=zh_cn&edition=full","pubTime":"2025-09-30 21:03","pubTimestamp":1759237388,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月30日市场公开信息、上市公司公告及交易所披露数据整理，仟源医药（300254）最新董监高及相关人员股份变动情况：2025年9月29日公司高管虞英民共减持公司股份1.0万股，占公司总股本为0.0039%。变动期间公司股价上涨0.19%，9月29日当日收盘报10.41元。仟源医药近半年内的董监高及核心技术人员增减持详情如下：仟源医药的高管列表及最新持股情况如下：该股最近90天内共有1家机构给出评级，买入评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000038375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","BK0042","BK0077","BK0046","300254","BK0028"],"gpt_icon":0},{"id":"2570903053","title":"仟源医药：新厂区增加精麻药品生产线","url":"https://stock-news.laohu8.com/highlight/detail?id=2570903053","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570903053?lang=zh_cn&edition=full","pubTime":"2025-09-25 09:01","pubTimestamp":1758762069,"startTime":"0","endTime":"0","summary":"证券之星消息，仟源医药(300254)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年9月17日，山西仟源医药集团股份有限公司隆重举行“‘筑梦新址·共赢未来’新厂区投运仪式”，请问新厂区主要生产什么医药项目，是否扩大相关医药产品的产量？仟源医药回复：投资者，您好！公司从旧厂区整体搬迁至新厂区，并增加了精麻药品（口服固体制剂和口服溶液剂）的生产线，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500004606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300254","BK0028","BK0077","BK0046","BK0114","BK0239"],"gpt_icon":0},{"id":"2570030508","title":"仟源医药：公司不涉及脑机接口的相关业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2570030508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570030508?lang=zh_cn&edition=full","pubTime":"2025-09-25 09:01","pubTimestamp":1758762069,"startTime":"0","endTime":"0","summary":"证券之星消息，仟源医药(300254)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：网传公司有涉及脑机接口的相关业务或技术储备，请问是否属实？仟源医药回复：投资者，您好！公司不涉及脑机接口的相关业务，请您以公司公告信息为准，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500004608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","300254","BK0042","BK0114","BK0028","BK0239"],"gpt_icon":0},{"id":"2570305470","title":"仟源医药：戒烟药线上市场份额增至24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570305470","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570305470?lang=zh_cn&edition=full","pubTime":"2025-09-25 09:01","pubTimestamp":1758762068,"startTime":"0","endTime":"0","summary":"证券之星消息，仟源医药(300254)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问帕瑞可戒烟药线上月销售量，是否逐月增长仟源医药回复：投资者，您好！自2024年公司开展线上业务以来，戒烟药酒石酸伐尼克兰片销量逐月稳步增长。根据中康网数据显示：该药品线上市场份额从2024年上半年的8%增长到2025年上半年的24%，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500004607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0077","300254","BK0114","BK0046","BK0239"],"gpt_icon":0},{"id":"2570030580","title":"仟源医药：未来药品若有合适机会将考虑拓展海外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2570030580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570030580?lang=zh_cn&edition=full","pubTime":"2025-09-25 09:01","pubTimestamp":1758762068,"startTime":"0","endTime":"0","summary":"证券之星消息，仟源医药(300254)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：未来公司的药是否有出海销售计划？仟源医药回复：投资者，您好！未来公司药品若有合适机会，将考虑拓展海外市场，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500004604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","BK0042","BK0077","BK0046","BK0028","300254"],"gpt_icon":0},{"id":"2569446733","title":"仟源医药（300254）披露拟申请不超1.2亿元银行授信，9月22日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569446733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569446733?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:46","pubTimestamp":1758552397,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘，仟源医药报收于10.46元，较前一交易日下跌1.41%，最新总市值为25.97亿元。该股当日开盘10.6元，最高10.75元，最低10.41元，成交额达7786.91万元，换手率为3.25%。根据公司近日发布的公告，山西仟源医药集团股份有限公司于2025年9月22日召开第五届董事会第三十四次会议，审议通过《关于向银行申请授信借款的议案》。该事项无需提交股东大会审议，董事会已授权管理层办理相关事宜并签署协议。表决结果：同意9票，反对0票，弃权0票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200034967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0114","161121","BK0239","BK0077","BK0042","300254"],"gpt_icon":0},{"id":"2568552458","title":"仟源医药：博时基金、申万宏源等多家机构于9月16日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2568552458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568552458?lang=zh_cn&edition=full","pubTime":"2025-09-17 09:11","pubTimestamp":1758071493,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年9月16日仟源医药发布公告称博时基金钟天皓 单朔 王诗瑶 刘煜舟、申万宏源张静含 仰佳佳于2025年9月16日调研我司。目前公司戒烟药酒石酸伐尼克兰片在线下连锁渠道销量最大。仟源医药主营业务：医药、保健食品的研发、生产、销售及医学诊断、基因保存、孕环境检测等医疗健康服务和商业业务等。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700009164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","BK0276","BK0028","BK0012","BK0042","BK0188","06806","300254","BK0077","BK0046","BK1147","000166","BK0239","BK0183","BK0114"],"gpt_icon":0},{"id":"2567148063","title":"仟源医药：新华基金、申万宏源等多家机构于9月15日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2567148063","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567148063?lang=zh_cn&edition=full","pubTime":"2025-09-15 23:02","pubTimestamp":1757948563,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年9月15日仟源医药发布公告称新华基金夏旭 赖庆鑫 赵东宇、申万宏源张静含于2025年9月15日调研我司。公司目前销售额最高的产品是泌尿系统药盐酸坦索罗辛缓释胶囊，其多年保持 2位数增长。仟源医药主营业务：医药、保健食品的研发、生产、销售及医学诊断、基因保存、孕环境检测等医疗健康服务和商业业务等。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500033894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300254","BK0276","BK1564","06806","BK1147","BK0028","BK0077","BK0012","BK0114","BK0239","BK0188","BK0042","BK0046","000166","BK0183"],"gpt_icon":0},{"id":"2567112363","title":"仟源医药：9月12日高管赵群增持股份合计147.99万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2567112363","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567112363?lang=zh_cn&edition=full","pubTime":"2025-09-15 21:02","pubTimestamp":1757941369,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月15日市场公开信息、上市公司公告及交易所披露数据整理，仟源医药（300254）最新董监高及相关人员股份变动情况：2025年9月12日公司董事,高管赵群共增持公司股份147.99万股，占公司总股本为0.596%。变动期间公司股价上涨2.95%，9月12日当日收盘报11.15元。仟源医药近半年内的董监高及核心技术人员增减持详情如下：仟源医药的高管列表及最新持股情况如下：该股最近90天内共有1家机构给出评级，买入评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500031132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0028","BK0077","300254","BK0114","BK0239"],"gpt_icon":0},{"id":"2566746549","title":"仟源医药：9月11日高管赵群增持股份合计60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566746549","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566746549?lang=zh_cn&edition=full","pubTime":"2025-09-12 21:02","pubTimestamp":1757682179,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月12日市场公开信息、上市公司公告及交易所披露数据整理，仟源医药（300254）最新董监高及相关人员股份变动情况：2025年9月11日公司董事,高管赵群共增持公司股份60.0万股，占公司总股本为0.2416%。变动期间公司股价上涨0.74%，9月11日当日收盘报10.83元。仟源医药近半年内的董监高及核心技术人员增减持详情如下：仟源医药的高管列表及最新持股情况如下：该股最近90天内共有1家机构给出评级，买入评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091200036038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0114","BK0239","BK0077","BK0042","300254"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766947291915,"stockEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0389},{"period":"3month","weight":-0.025},{"period":"6month","weight":0.0379},{"period":"1year","weight":0.1644},{"period":"ytd","weight":0.1577}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山西仟源医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24916人(较上一季度增加13.25%)","perCapita":"9005股","listingDate":"2011-08-19","address":"山西省大同市云州区大同经济技术开发区生物科技创新产业园翠微街2号","registeredCapital":"25610万元","survey":"　　山西仟源医药集团股份有限公司的主营业务是医药、保健食品的研发、生产、销售及医学诊断、基因保存、孕环境检测。公司的主要产品是磷霉素氨丁三醇散、依巴斯汀片、盐酸坦索罗辛缓释胶囊、酒石酸伐尼克兰片、蒙脱石散、维生素AD滴剂、盐酸氨溴索分散片、盐酸舍曲林片、盐酸氟西汀胶囊、盐酸西那卡塞片、阿哌沙班片、利伐沙班片、精氨酸培哚普利片、保灵牌孕宝口服液、DNA基因保存。","listedPrice":13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仟源医药(300254)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仟源医药(300254)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仟源医药,300254,仟源医药股票,仟源医药股票老虎,仟源医药股票老虎国际,仟源医药行情,仟源医药股票行情,仟源医药股价,仟源医药股市,仟源医药股票价格,仟源医药股票交易,仟源医药股票购买,仟源医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仟源医药(300254)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仟源医药(300254)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}